The U.S. Food and Drug Administration this week warned CVS Health Corp. Walgreens Boots Alliance Inc. and several smaller consumer products companies about...
The U.S. Food and Drug Administration this week warned CVS Health Corp. CVS, +3.00%, Walgreens Boots Alliance Inc. WBA, +2.85% and several smaller consumer products companies about marketing unapproved eye products. “The FDA is particularly concerned that these illegally marketed, unapproved ophthalmic drug products pose a heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses,” the FDA said in a release Tuesday.
The FDA’s letter to CVS contained similar warnings about “CVS Health Pink Eye Relief Drops” offered through the CVS website. Both letters also raised concerns about the manufacturing practices of contract manufacturers producing the products. The FDA asked the companies to notify the agency of steps taken to correct the violations within 15 working days.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA issues warning letter to CVS, Walgreens and others for selling unapproved eye products By ReutersFDA issues warning letter to CVS, Walgreens and others for selling unapproved eye products
Weiterlesen »
Walgreens Boots, Goldman Sachs share gains lead Dow's nearly 100-point jumpThe Dow Jones Industrial Average is trading up Tuesday afternoon with shares of Walgreens Boots and Goldman Sachs delivering the strongest returns for the...
Weiterlesen »
Walgreens In Deal With Tech Firm Pearl Health To Enhance Work With Primary Care DoctorsWalgreens has partnered with the technology company Pearl Health to assist primary care doctors with software and services they need in the shift to value-based care.
Weiterlesen »
4 big analyst picks: CVS picks up upgrade on 'attractive risk/reward,' per Wolfe By Investing.com4 big analyst picks: CVS picks up upgrade on 'attractive risk/reward,' per Wolfe
Weiterlesen »
Here are Tuesday's biggest analyst calls: Nvidia, Tesla, CVS, Oracle, Walmart, Meta, Disney and moreHere are the biggest calls on Wall Street on Tuesday.
Weiterlesen »
SA germ-zapping robot-maker Xenex clears major FDA hurdleThe U.S. Food and Drug Administration has granted Xenex Disinfection Services a De Novo authorization for its LightStrike+ device.
Weiterlesen »